IN-LICENSING AS A BUSINESS STRATEGY FOR PHARMACEUTICAL COMPANIES: A FRAMEWORK FOR THE NIGERIAN INDUSTRY

被引：1
|
作者：
Keshi, C. B. [1 ]
机构：
[1] UGSM, Zug, Switzerland
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.08.635
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP52
引用
收藏
页码：A823 / A823
页数：1
相关论文
共 50 条
  • [1] In-licensing as a business model
    Dennis P. Schafer
    [J]. Nature Biotechnology, 2002, 20 : BE36 - BE39
  • [2] In-licensing as a business model
    Schafer, DP
    [J]. NATURE BIOTECHNOLOGY, 2002, 20 (Suppl 6) : BE36 - BE39
  • [3] MARKET ACCESS CONSIDERATIONS IN PHARMACEUTICAL IN-LICENSING VALUATIONS
    Ohanjanyan, A.
    Mukku, S.
    Edathodu, A.
    Samuel, J.
    Leung, S. K.
    Digiacomo, F.
    Golzalez, Olid A.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A195 - A195
  • [4] Ensuring Quality Science From "R" to "D": An Optimal Adoption Strategy for In-Licensing of Pharmaceutical Innovation
    Zhao, Guozhen
    Chen, Wen
    [J]. IEEE TRANSACTIONS ON ENGINEERING MANAGEMENT, 2011, 58 (04) : 643 - 661
  • [5] LICENSING AS PART OF BUSINESS STRATEGY
    NOONE, TM
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1984, 187 (APR): : 11 - SCHB
  • [6] Decrease in licensing agreements as pharmaceutical companies reign in spending
    不详
    [J]. PHARMACEUTICAL PATENT ANALYST, 2012, 1 (01) : 21 - 21
  • [7] Inbound open innovation for pharmaceutical markets: a case study of an anti-diabetic drug in-licensing decision
    Wu, Allan Ya-Huan
    Little, Victoria Janine
    Low, Brian
    [J]. JOURNAL OF BUSINESS & INDUSTRIAL MARKETING, 2016, 31 (02) : 205 - 218
  • [8] IT INNOVATION AND TECNOLOGY LICENSING BUSINESS STRATEGY
    Chen, Wenhua
    Tao, Changqi
    Feng, Wenna
    [J]. PROCEEDINGS OF ACADEMY OF INNOVATION AND ENTREPRENEURSHIP 2009, 2009, : 16 - 21
  • [9] Mathematical modeling and pharmaceutical pricing: Analyses used to inform in-licensing and developmental Go/No-Go decisions
    Vernon J.A.
    Hughen W.K.
    Johnson S.J.
    [J]. Health Care Management Science, 2005, 8 (2) : 167 - 179
  • [10] Chinese pharmaceutical companies: an emerging industry
    Jiang, Y
    Wang, YF
    Yan, XJ
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (12) : 610 - 612
12345